PL446676A1 - Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję - Google Patents

Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję

Info

Publication number
PL446676A1
PL446676A1 PL446676A PL44667623A PL446676A1 PL 446676 A1 PL446676 A1 PL 446676A1 PL 446676 A PL446676 A PL 446676A PL 44667623 A PL44667623 A PL 44667623A PL 446676 A1 PL446676 A1 PL 446676A1
Authority
PL
Poland
Prior art keywords
cigarette
composition
liquid composition
cigarette liquid
cigarette containing
Prior art date
Application number
PL446676A
Other languages
English (en)
Inventor
Dmitrii Shesternenko
Original Assignee
Dmitrii Shesternenko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmitrii Shesternenko filed Critical Dmitrii Shesternenko
Priority to PL446676A priority Critical patent/PL446676A1/pl
Priority to PCT/IB2024/061134 priority patent/WO2025099687A1/en
Publication of PL446676A1 publication Critical patent/PL446676A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Przedmiotem niniejszego zgłoszenia jest kompozycja płynu do e-papierosa zawierająca wodę jako jedyny lub główny nośnik substancji aktywnej i aromatu oraz zasadniczo nie zawierająca glikolu propylenowego ani gliceryny oraz e-papieros zawierający taką kompozycję.
PL446676A 2023-11-08 2023-11-08 Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję PL446676A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL446676A PL446676A1 (pl) 2023-11-08 2023-11-08 Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję
PCT/IB2024/061134 WO2025099687A1 (en) 2023-11-08 2024-11-08 Liquid composition for e-cigarette and e-cigarette containing such composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL446676A PL446676A1 (pl) 2023-11-08 2023-11-08 Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję

Publications (1)

Publication Number Publication Date
PL446676A1 true PL446676A1 (pl) 2025-05-12

Family

ID=95653662

Family Applications (1)

Application Number Title Priority Date Filing Date
PL446676A PL446676A1 (pl) 2023-11-08 2023-11-08 Kompozycja liquidu do e-papierosa oraz e-papieros zawierający taką kompozycję

Country Status (2)

Country Link
PL (1) PL446676A1 (pl)
WO (1) WO2025099687A1 (pl)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112617272A (zh) * 2019-10-09 2021-04-09 普济生物科技（台州）有限公司 一种水基质雾化液的电子烟烟油
CN113057365A (zh) * 2021-03-21 2021-07-02 浙江普绿世新材料科技有限公司 一种电子烟用水基雾化液
EP3906794A1 (en) * 2019-01-25 2021-11-10 China Tobacco Hunan Industrial Co., Ltd. Water-based electronic cigarette liquid
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574902A1 (en) * 2018-06-01 2019-12-04 Yatzz Limited Nicotine formulation and mode of delivery
CN117615663A (zh) * 2021-02-24 2024-02-27 莱战略控股公司 气溶胶前体制剂
CN115736322B (zh) * 2022-12-09 2026-04-24 深圳市真味生物科技有限公司 一种雾化基液、雾化液及减少气溶胶小粒径粒子的方法
CN118787123A (zh) * 2023-04-14 2024-10-18 思摩尔国际控股有限公司 一种水基电子烟雾化制剂及其制备方法和应用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906794A1 (en) * 2019-01-25 2021-11-10 China Tobacco Hunan Industrial Co., Ltd. Water-based electronic cigarette liquid
CN112617272A (zh) * 2019-10-09 2021-04-09 普济生物科技（台州）有限公司 一种水基质雾化液的电子烟烟油
CN113057365A (zh) * 2021-03-21 2021-07-02 浙江普绿世新材料科技有限公司 一种电子烟用水基雾化液
WO2023116047A1 (en) * 2021-12-22 2023-06-29 Shenzhen Fumiao Biotechnology Co., Ltd Water-based atomizing agent, water-based atomizing substance for specified purpose, cartomizer and atomizing device

Also Published As

Publication number Publication date
WO2025099687A1 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
CL2021003191A1 (es) Inhibidores de tead y usos de los mismos
CL2021003190A1 (es) Inhibidores de tead y usos de los mismos
MX2020007945A (es) Proteinas f del rsv estabilizadas y usos de las mismas.
RU2013137460A (ru) Способ окраски или осветления кератиновых волокон в два приема с использованием обогащенной маслом прямой щелочной эмульсии на основе твердого неионогенного поверхностно-активного вещества со значением гидрофильно-липофильного баланса от 1 до 10
DOP2012000314A (es) Compuestos, composiciones de tiocetato y metodos de uso
CR20210270A (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de los mismos
ES2612521T3 (es) Composición de colorante de oxidación que comprende un policondensado de óxido de etileno y de óxido de propileno y un alcohol graso insaturado
MX2018014631A (es) Formulacion de neurotoxina.
EA201991988A1 (ru) Композиции и способы для способствования росту волос с помощью ингибиторов mpc1
CR20180057A (es) Nuevos compuestos biciclicos como inhibidores duales de atx/ca.
EA201992520A1 (ru) Масло, улучшающее композицию для кожи
EA201992721A1 (ru) Способы получения и применения ингибиторов pde9
CO2018012502A2 (es) Formulaciones y métodos para el tratamiento de organismos fotosintéticos y la mejora de las calidades y cantidades de rendimientos con formulaciones de compuestos de glicano
MX2022007009A (es) Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion.
AU2020235128A8 (en) Transparent or semitransparent inverse microlatices of polyacrylamide as oil emulsion drift reducing agent
MX2021009142A (es) Inhibidores topicos de fosfoinositol 3-cinasas.
MX2021005120A (es) Formulacion aerosolizada.
CO2021014255A2 (es) Composiciones antifúngicas
MA37880A1 (fr) Formulation transdermique contenant des inhibiteurs de cox
NZ768564A (en) Formulation of insecticidal mixtures comprising propylene carbonate
EA202191341A1 (ru) Твердый состав гербицидной композиции и способ его получения
MA50116A1 (fr) Agent d'absorption transdermique comprenant du donépézil pour le traitement de la démence
MX2021008071A (es) Derivados de imidazol fusionado sustituido y métodos de tratamiento de la anemia de células falciformes y complicaciones relacionadas.
EA202190695A1 (ru) Композиция поверхностно-активных веществ и ее применение
CO2017008372A2 (es) Derivados del ácido (2r)-3-amino-2-(bi-cíclicopiridilmetil)-2-hidroxi-propanoico como inhibidores de p-lap